Skip to content
Colorectal Cancer Drug Research MS
Menu
About
Science
News & Events
Contact Us
Press Releases
February 19, 2020 - Barricade Therapeutics receives $3M product development seed award from the Cancer Prevention Research Institute of Texas (CPRIT).
https://www.cprit.state.tx.us/news-events/articles/cancer-prevention-research-institute-of-texas-awards-78-million-in-new-grants/
February 20, 2020 - North Texas startups, renowned UTSW researcher attract $21 million from Texas cancer fighting agency
https://www.dallasnews.com/business/health-care/2020/02/20/north-texas-startups-renowned-utsw-researcher-attract-21-million-from-texas-cancer-fighting-agency/
Events
Barricade Therapeutics is planning to attend and/or presenting at the following upcoming events:
ASCO – American Society of Clinical Oncology Annual Meeting
BIO International Convention
TASIN Colorectal Cancer Publications:
Selective targeting of mutant adenomatous polyposis coli in colorectal cancer.
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer.
TASIN Neurology Publications:
Accumulation of 8,9-unsaturated sterols drives oligodendrocyte formation and remyelination.